241
Participants
Start Date
June 20, 2023
Primary Completion Date
April 1, 2026
Study Completion Date
October 1, 2027
Pre-treatment biopsy
Pre-treatment fragments will be collected during the biopsy visit organised as part of routine medical practice, prior to the start of treatment with ribociclib + ET
Post treatment biopsy
Post-treatment fragments will be collected during a biopsy visit specifically planned for Trans-RosaLEE study.
Pre treatment blood sampling
Sampling of 4 EDTA Tubes (4ml) and 2 Streck tubes (10ml)
Post treatment blood sampling
Sampling of 2 Streck tubes (10ml)
RECRUITING
Institut Paoli Calmettes, Marseille
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Institut Paoli-Calmettes
OTHER